Register for our events and seminars.
Read our latest news and information.
Join the conversation online!
Article
Hong Kong's largest pre-revenue biotech listing so far this year
Chinese NEV company sets sector record for shortest time between establishment and US IPO
The largest Hong Kong IPO so far this year
1st European gaming company to list in Hong Kong
Deloitte China’s 1st new listing in the Year of Dragon
HK's largest LSHC IPO so far in 2023
1st NEEQ and H share dual-listed VC organisation; 1st HK-listed Chinese PE fund
Deloitte has been reporting accountant for more pre-revenue biotech IPOs in Hong Kong than any other professional services firm so far in 2023
2nd pre-revenue biotech listing assisted by Deloitte in Hong Kong this year
1st catering supply chain listing in A-share market
The largest Shanghai MB IPO in nearly a decade
1st spin-off listing of an SOE on SSE STAR Market; Deloitte China as the 1st audit institution among the Big Four to support a SOE spin-off listing in the A-share market
Among Chinese Mainland's 1st batch of publicly listed and traded public infrastructure REITs
Hong Kong's 2nd largest IPO this year; Deloitte's 3rd Hong Kong IPO engagement for JD.com
Insert Custom CSS fragment. Do not delete! This box/component contains code needed on this page. This message will not be visible when page is activated.
